Emergex Vaccines
Pioneering a new approach to vaccine development and manufacturing using cutting-edge technologies to produce novel synthetic vaccines.
Total raised
€9.9M
€9,900,000
Funding rounds
1
Investors
1
distinct backers
Active since
2020-08
latest 2020-08
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-01 | Series A | €9.9M | Vickers Venture Partners | View deal → |